Teppo A M, Kurki P, Helve T, Wegelius O
Rheumatol Int. 1984;4(4):173-6. doi: 10.1007/BF00541210.
The relationship between immunoglobulin class and complement-binding ability of DNA antibodies was studied by indirect immunofluorescence and Crithidia luciliae (CL) as substrate in the sera of 28 patients with SLE and antibodies to CL-DNA. In 15 of 28 cases the antibodies bound complement and were IgG either alone or in combination with IgA and IgM. In the remaining 13 sera the antibodies were either IgA or IgM and did not bind complement. Only one of nine patients with nephritis had CL-DNA antibodies of IgM alone, whereas that was true for 10 of 19 patients without nephritis. The factors influencing the complement binding were further studied by using purified IgM rheumatoid factors. Their ability to 'mask' the IgG-type CL-DNA antibodies and to inhibit the binding of complement was confirmed. These findings suggest that complement activation in SLE does not occur in patients with IgM-type anti-ds-antibodies or in patients with rheumatoid factor activity.
以间接免疫荧光法和克氏锥虫(CL)为底物,研究了28例系统性红斑狼疮(SLE)患者血清中DNA抗体的免疫球蛋白类别与补体结合能力之间的关系,这些患者均有抗CL - DNA抗体。28例中有15例抗体结合补体,且单独为IgG或与IgA和IgM联合存在。其余13份血清中的抗体为IgA或IgM,不结合补体。9例肾炎患者中仅1例有单独IgM型的CL - DNA抗体,而19例无肾炎患者中有10例是这种情况。通过使用纯化的IgM类风湿因子进一步研究影响补体结合的因素。证实了它们“掩盖”IgG型CL - DNA抗体并抑制补体结合的能力。这些发现表明,SLE中补体激活在IgM型抗双链抗体患者或有类风湿因子活性的患者中不会发生。